Intestinal IgA B cell receptor-specific signals integrate germinal center selection with humoral responses to commensals

肠道 IgA B 细胞受体特异性信号将生发中心选择与对共生体的体液反应结合起来

基本信息

  • 批准号:
    10574777
  • 负责人:
  • 金额:
    $ 25.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-11-09 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

Abstract B lymphocytes in the gastrointestinal tract are constantly stimulated by microbial antigens. In order to prevent commensal outgrowth and maintain intestinal homeostasis, B cells need to mount a rapid antibody response against bacterial antigens. To achieve this task, the humoral immune system relies on a complex multistep process of B cell proliferation and selection in the germinal center, which eventually gives rise to either antibody-secreting plasma cells or memory B cells. Intestinal B cells are mainly expressing immunoglobulin A (IgA), but how this specific antigen receptor isotype shapes B cell fate and antibody response in the gut is poorly understood. Moreover, dysregulation of IgA response is associated with increased infection susceptibility and autoinflammation at the mucosal interfaces. Therefore, elucidating the fundamental mechanisms that intrinsically regulate the fate and function of individual B cell clones in the gut remains a central question in immunology with clear translational implications. Several lines of evidence indicate that distinct B cell receptor isotypes act as intrinsic regulators of germinal center B cell response. However, how B cells integrate IgA antigen receptor signaling with germinal center dynamics and antibody response remains undefined to date. In this application we test the hypothesis that surface IgA directly controls germinal center B cell response through its enhanced intracellular signaling and Ca2+ release. This leads to the generation of a lower threshold of B cell activation, therefore allowing B cell specific for poorly immunogenic commensal species to be recruited into the germinal center and to participate to the humoral response. We also hypothesize that IgA signaling prevents counterselection mediated by FAS, allowing survival of low affinity B cells. Accumulating evidence indicates IgA coating of commensals is less dependent on antigen affinity, but the mechanisms underpinning this phenotype have not been investigated so far. Our aims are: 1) to dissect the role of IgA-dependent BCR signaling on cell migration into the intestinal tissue and on the quality of the antibody response; and 2) to define the role of Fas-FasL axis in counter- selecting mucosal IgA+ germinal center B cells for efficient intestinal response. The proposed studies examine a very poorly understood crosstalk between IgA signaling and adaptive immune system activation in the gut. It is our expectation that these studies will increase our understanding of how intestinal antigen recognition shapes B cell responses and adaptive immunity both at steady state and during enteric infections. Furthermore, our studies will provide a foundation for better understanding of the relationship between BCR-intracellular signaling and differentiation of gut-homing B lymphocytes that assure mucosal humoral immunity.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea Reboldi其他文献

Andrea Reboldi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea Reboldi', 18)}}的其他基金

Embryonic type 3 innate lymphoid cells sense maternal dietary cholesterol to shape mucosal lymphoid organ development
胚胎 3 型先天淋巴细胞感知母体饮食胆固醇以塑造粘膜淋巴器官发育
  • 批准号:
    10510646
  • 财政年份:
    2022
  • 资助金额:
    $ 25.13万
  • 项目类别:
Embryonic type 3 innate lymphoid cells sense maternal dietary cholesterol to shape mucosal lymphoid organ development
胚胎 3 型先天淋巴细胞感知母体饮食胆固醇以塑造粘膜淋巴器官发育
  • 批准号:
    10632055
  • 财政年份:
    2022
  • 资助金额:
    $ 25.13万
  • 项目类别:
Diet-derived oxysterols shape intestinal B cell fate by controlling intracellular cholesterol metabolism
饮食来源的氧甾醇通过控制细胞内胆固醇代谢来塑造肠道 B 细胞的命运
  • 批准号:
    10626049
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
Diet-derived oxysterols shape intestinal B cell fate by controlling intracellular cholesterol metabolism
饮食来源的氧甾醇通过控制细胞内胆固醇代谢来塑造肠道 B 细胞的命运
  • 批准号:
    10299176
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
Diet-derived oxysterols shape intestinal B cell fate by controlling intracellular cholesterol metabolism
饮食来源的氧甾醇通过控制细胞内胆固醇代谢来塑造肠道 B 细胞的命运
  • 批准号:
    10437926
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 25.13万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 25.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了